University of Pennsylvania Annual Conference on
Statistical Issues in Clinical Trials:
From Bench to Bedside to Community
April 29, 2009
Topic for 2009 Conference:
Targeted Therapies
 |
University of Pennsylvania School of Medicine |
The 2009 Conference will focus on targeted clinical trials. The Conference will bring together leading scientists who will make presentations and lead open discussions on state-of-the-art and developing methods. A range of topics linked closely to translational medicine will be examined. The Conference will conclude with a panel discussion to synthesize and challenge earlier presentations, as well as to propose future directions. Scholarly exchange of ideas and lively discussions are expected. Participants from academic institutions, industry and governmental agencies with interest in contributing to these discussions are encouraged to register.
Organizers: |
Funding Sponsor: |
Co-Sponsors: |
| Jonas Ellenberg Susan Ellenberg |
NIH NCI Grant R13-CA132565 | American Statistical Association and the Society for Clinical Trials |
Slides for the presentations made during the conference are available by clicking the individual links in the "Topics" column below. |
||
| Faculty | Institution | Topic |
|---|---|---|
| Stephen Friend | Merck/Sage | Grasping the complexity to see the simplicity |
| Richard Simon | National Cancer Institute | Clinical trials for predictive medicine - New challenges and paradigms |
| Sue-Jane Wang | Food and Drug Administration | Regulatory Perspectives on statistical design in pharmacogenomic clinical trials |
| Aiyi Liu | University of Wisconsin | Threshold sample enrichment approach - Heterogeneous populations in clinical trial for preeclampsia |
| KyungMann Kim | University of Wisconsin | A response adaptive design with pharmacogenomic biomarkers for targeted therapies |
| Andrew Zhou | University of Washington | Evaluating markers for treatment selection based on survival time |
| Emilia Bagiella | Columbia University | Multiple interventions for multiple targets |
| Daniel Sargent, PhD | Mayo Clinic | Predictive biomarker validation in practice: Lessons from real trials |
| Stephen Ruberg | Eli Lilly | The mean doesn't mean as much anymore |
| J. Jack Lee | MD Anderson | Bayesian adaptive design for targeted therapy development - For cancer and "other" areas |
| Jungnam Joo | National Heart, Lung, and Blood Institute | Genetic guided dosing of Warfarin for anticoagulation |
Preliminary Program:
Please click here for a PDF of the program.
For additional information, contact:
Donna Zikowitz
Phone: 215-573-2728 Email: zikowitz@mail.med.upenn.edu
